B Lymphoblastic Lymphoma
7 clinical trials · Condition
◉ Watch B Lymphoblastic Lymphoma
| Record | Firm | Date |
|---|---|---|
| Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy (NCT03959085) | Children's Oncology Group | 2019-10-31 |
| A Study to Investigate Blinatumomab in Combination With Chemotherapy in Patients With Newly Diagnosed B-Lymphoblastic Leukemia (NCT03914625) | National Cancer Institute (NCI) | 2019-07-03 |
| Blinatumomab, Inotuzumab Ozogamicin, and Combination Chemotherapy as Frontline Therapy in Treating Patients With B Acute Lymphoblastic Leukemia (NCT02877303) | M.D. Anderson Cancer Center | 2016-11-01 |
Track B Lymphoblastic Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.